| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 274.91B | 284.07B | 254.51B | 300.59B | 257.23B | 213.73B |
| Gross Profit | 32.47B | 34.25B | 31.43B | 34.17B | 28.10B | 21.21B |
| EBITDA | 34.09B | 38.65B | 35.14B | 38.83B | 33.69B | 26.78B |
| Net Income | 51.83B | 31.86B | 27.79B | 27.23B | 17.89B | 39.16B |
Balance Sheet | ||||||
| Total Assets | 626.65B | 626.06B | 679.14B | 573.69B | 562.19B | 535.76B |
| Cash, Cash Equivalents and Short-Term Investments | 52.17B | 63.39B | 61.02B | 64.00B | 52.96B | 61.88B |
| Total Debt | 123.22B | 118.10B | 119.34B | 107.77B | 104.77B | 109.15B |
| Total Liabilities | 251.13B | 246.78B | 267.44B | 219.25B | 214.43B | 208.93B |
| Stockholders Equity | 370.79B | 374.67B | 405.43B | 350.80B | 344.08B | 323.60B |
Cash Flow | ||||||
| Free Cash Flow | -7.44B | 16.46B | 23.51B | 20.07B | -1.79B | 451.00M |
| Operating Cash Flow | 9.76B | 29.62B | 41.77B | 40.49B | 36.22B | 40.18B |
| Investing Cash Flow | 11.31B | 15.50B | -31.48B | -14.38B | -29.22B | -14.00B |
| Financing Cash Flow | -26.39B | -44.19B | -14.86B | -17.07B | -16.52B | -5.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥420.72B | 10.72 | 11.08% | 2.55% | 6.45% | 24.72% | |
68 Neutral | ¥983.37B | 10.15 | 9.97% | 3.54% | 12.46% | -3.12% | |
68 Neutral | ¥496.07B | 11.01 | 13.93% | 2.81% | 8.22% | 48.07% | |
67 Neutral | ¥307.08B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
66 Neutral | ¥319.23B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥918.66B | 310.63 | ― | 2.99% | 4.96% | 1.67% |